The differential effect of NAT2 variant alleles permits refinement in phenotype inference and identifies a very slow acetylation genotype
about
Arylamine N-acetyltransferases: from drug metabolism and pharmacogenetics to drug discoveryPharmGKB summary: very important pharmacogene information for N-acetyltransferase 2Variation in NAT2 acetylation phenotypes is associated with differences in food-producing subsistence modes and ecoregions in Africa.Anti-Parkinson's disease drugs and pharmacogenetic considerations.Urinary bladder cancer risk factors in an area of former coal, iron, and steel industries in Germany.NAT2 polymorphisms and risk for Parkinson's disease: a systematic review and meta-analysis.NAT2 genetic variations among South Indian populations.NAT2 gene diversity and its evolutionary trajectory in the Americas.NAT2 Genotype and Isoniazid Medication in Children.Toward a clinical practice guide in pharmacogenomics testing for functional polymorphisms of drug-metabolizing enzymes. Gene/drug pairs and barriers perceived in Spain.Refinement of the prediction of N-acetyltransferase 2 (NAT2) phenotypes with respect to enzyme activity and urinary bladder cancer risk.Dapsone-induced agranulocytosis-possible involvement of low-activity N-acetyltransferase 2.Catalytic properties and heat stabilities of novel recombinant human N-acetyltransferase 2 allozymes support existence of genetic heterogeneity within the slow acetylator phenotype.Genetic heterogeneity among slow acetylator N-acetyltransferase 2 phenotypes in cryopreserved human hepatocytes.Studies on N-Acetyltransferase (NAT2) Genotype Relationships in Emiratis: Confirmation of the Existence of Phenotype Variation among Slow Acetylators.Association between the PINX1 and NAT2 polymorphisms and serum lipid levels.The ultra-slow NAT2*6A haplotype is associated with reduced higher cognitive functions in an elderly study group.
P2860
Q26995125-9AFA43E1-ABBA-47E0-BE34-6351C01FB2ADQ27011622-4E615E66-7B41-4A79-98B2-3F216CE5294BQ35856283-0831910B-6E62-45F9-B6AE-5132C4359952Q38097097-B1EC5755-1FF1-488D-A2EA-5FF242D5808BQ38399978-6EF14B86-7A41-447E-9CF7-3C4201097C89Q38842411-7274B1D0-4F16-469A-AEE9-6BF99411EB8BQ38893783-2B219B12-8F8C-413E-974E-EA8EFA81FFC9Q40390254-6D6C573F-AB0A-400D-82CD-92E9FCAAE8EAQ42387608-DBEF3241-ED15-4808-9CEA-3589F5EF7F4FQ42394160-3F1DCC8E-3AF9-4F5E-9158-113AFCF8A1A6Q42708451-7D24EF88-FCB7-4536-9034-A2609A1A2DD3Q48098830-FB930020-BF68-421F-8510-0B225167E3EFQ48123467-CC9BA3ED-AD6B-42CD-AE6B-5A1F79285F9DQ48129221-E6E18946-F8B7-4213-A542-56DEF4498821Q48217924-20D60503-1281-423A-902C-D7C04E66AEC0Q49294719-B551C279-4F4C-48BB-96D0-C3D04A1397BBQ50317492-CF840C44-8A12-4D96-8B94-59483AD35382
P2860
The differential effect of NAT2 variant alleles permits refinement in phenotype inference and identifies a very slow acetylation genotype
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
The differential effect of NAT ...... very slow acetylation genotype
@ast
The differential effect of NAT ...... very slow acetylation genotype
@en
The differential effect of NAT ...... very slow acetylation genotype
@nl
type
label
The differential effect of NAT ...... very slow acetylation genotype
@ast
The differential effect of NAT ...... very slow acetylation genotype
@en
The differential effect of NAT ...... very slow acetylation genotype
@nl
prefLabel
The differential effect of NAT ...... very slow acetylation genotype
@ast
The differential effect of NAT ...... very slow acetylation genotype
@en
The differential effect of NAT ...... very slow acetylation genotype
@nl
P2093
P2860
P1433
P1476
The differential effect of NAT ...... very slow acetylation genotype
@en
P2093
Carmen Martínez
Jhon D Ruiz
Kristin Anderson
Myron Gross
Nicholas P Lang
P2860
P304
P356
10.1371/JOURNAL.PONE.0044629
P407
P577
2012-09-06T00:00:00Z